Cutaneous PEComa does not harbour TFE3 gene fusions: Immunohistochemical and molecular study of 17 cases

Histopathology

Volumn 63, Issue 1, 2013, Pages 122-129

  Llamas Velasco, Mar ^a   Mentzel, Thomas ^b   Requena, Luis ^c   Palmedo, Gabriele ^b   Kasten, Robert ^d   Kutzner, Heinz ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Dermatopathologie Bodensee ^*  (Germany)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d Facharzt für Dermatologie und Venereologie   (Germany)

Author keywords

Gene fusion; PEComa; Perivascular epithelioid cells; Skin

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10; TUMOR MARKER;

ADULT; AGED; ARTICLE; CELLS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; EPITHELIOID CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER LEG; MALE; NEURAL CREST; PERIVASCULAR EPITHELIOID CELL TUMOR; PRIORITY JOURNAL; REGULATOR GENE; SKIN COLOR; SKIN TUMOR; SPINDLE CELL; TFE3 GENE;

ADULT; AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; EPITHELIOID CELLS; FEMALE; GENE FUSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PERIVASCULAR EPITHELIOID CELL NEOPLASMS; SOXE TRANSCRIPTION FACTORS;

EID: 84879461342     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12145     Document Type: Article

References (20)

1. Hornick JL, Pan CC. PEComa. In Fletcher CD, Bridge J, Hogendoorn PCW, Marteus F eds. World Health Organization classification of tumours of soft tissue and bones. Lyon: IARC Press, 2013; 230-231.
2. Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum. Pathol. 2010; 41; 1-15.
3. Crowson AN, Taylor JR, Magro C. Cutaneous clear cell myomelanocytic tumor-perivascular epithelioid cell tumor: first reported case. Mod. Pathol. 2003; 16; 400.
4. Mentzel T, Reisshauer S, Rutten A, Hantschke M. Soares de Almeida LM, Kutzner H. Cutaneous clear cell myomelanocytic tumour: a new member of the growing family of perivascular epithelioid cell tumours (PEComas). Clinicopathological and immunohistochemical analysis of seven cases. Histopathology 2005; 46; 498-504.
5. Liegl B, Hornick JL, Fletcher CD. Primary cutaneous PEComa: distinctive clear cell lesions of skin. Am. J. Surg. Pathol. 2008; 32; 608-614.
6. Walsh SN, Sangueza OP. PEComas: a review with emphasis on cutaneous lesions. Semin. Diagn. Pathol. 2009; 26; 123-130.
7. Calder KB, Schlauder S, Morgan MB. Malignant perivascular epithelioid cell tumor ('PEComa'): a case report and literature review of cutaneous/subcutaneous presentations. J. Cutan. Pathol. 2008; 35; 499-503.
8. Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am. J. Surg. Pathol. 2005; 29; 1558-1575.
9. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch. 2008; 452; 119-132.
10. Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P. Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am. J. Surg. Pathol. 2012; 36; 783-784.
11. Argani P, Ladanyi M. Kidney: t(X;17)(p11.2;q23) in renal cell carcinoma. Atlas Genet. Cytogenet. Oncol. Haematol., 2005; 9; 263-265. URL: http://AtlasGeneticsOncology.org/Tumors/RenalCellt0X17ID5035.html [Accessed 22/05/2013]
12. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 2003; 27; 750-761.
13. Argani P, Lui MY, Couturier J, Bouvier R, Fournet JC, Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 2003; 22; 5374-5378.
14. Ramos-Herberth FI, Karamchandani J, Kim J, Dadras SS. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. J. Cutan. Pathol. 2010; 37; 944-952.
15. Kuroda N, Goda M, Kazakov DV, Hes O, Michal M, Lee GH. Perivascular epithelioid cell tumor of the nasal cavity with TFE3 expression. Pathol. Int. 2009; 59; 769-770.
16. Argani P, Aulmann S, Illei PB et al. A distinctive subset of PEComas harbors TFE3 gene fusions. Am. J. Surg. Pathol. 2010; 34; 1395-1406.
17. Tanaka M, Kato K, Gomi K et al. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am. J. Surg. Pathol. 2009; 33; 1416-1420.
18. Lee SE, Choi YL, Cho J, Kim T, Song SY, Sung CO. Ovarian perivascular epithelioid cell tumor not otherwise specified with transcription factor E3 gene rearrangement: a case report and review of the literature. Hum. Pathol. 2012; 43; 1126-1130.
19. Ohe C, Kuroda N, Hes O et al. A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH. Med. Mol. Morphol. 2012; 45; 234-237.
20. Tsuji K, Ishikawa Y, Imamura T. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript. Hum. Pathol. 2012; 43; 356-363.